A detailed history of Ropes Wealth Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 7,758 shares of AMGN stock, worth $2.28 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
7,758
Previous 7,852 1.2%
Holding current value
$2.28 Million
Previous $1.74 Million 19.62%
% of portfolio
0.41%
Previous 0.29%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $20,553 - $25,517
-94 Reduced 1.2%
7,758 $2.09 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $67,280 - $79,558
314 Added 4.17%
7,852 $1.74 Million
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $30,255 - $36,876
-134 Reduced 1.75%
7,538 $1.82 Million
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $319,954 - $406,540
1,397 Added 22.26%
7,672 $2.01 Million
Q3 2022

Nov 01, 2022

BUY
$224.46 - $253.15 $47,809 - $53,920
213 Added 3.51%
6,275 $1.41 Million
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $20,533 - $22,849
-89 Reduced 1.45%
6,062 $1.48 Million
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $65,781 - $72,771
-300 Reduced 4.65%
6,151 $1.49 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $110,179 - $126,090
-554 Reduced 7.91%
6,451 $1.45 Million
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $68,563 - $80,330
-323 Reduced 4.41%
7,005 $1.49 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $15,182 - $16,844
-65 Reduced 0.88%
7,328 $1.79 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $53,036 - $61,805
239 Added 3.34%
7,393 $1.87 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $7,356 - $8,760
-34 Reduced 0.47%
7,154 $1.65 Million
Q3 2020

Oct 16, 2020

BUY
$234.65 - $260.95 $64,528 - $71,761
275 Added 3.98%
7,188 $1.83 Million
Q2 2020

Jul 20, 2020

BUY
$197.81 - $242.74 $89,410 - $109,718
452 Added 7.0%
6,913 $1.63 Million
Q1 2020

Apr 24, 2020

BUY
$182.24 - $241.7 $26,060 - $34,563
143 Added 2.26%
6,461 $1.31 Million
Q4 2019

Feb 05, 2020

SELL
$189.21 - $243.2 $187,128 - $240,524
-989 Reduced 13.53%
6,318 $1.52 Million
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $80,612 - $96,591
463 Added 6.77%
7,307 $1.41 Million
Q2 2019

Jul 31, 2019

SELL
$166.7 - $195.41 $30,839 - $36,150
-185 Reduced 2.63%
6,844 $1.26 Million
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $7,671 - $8,954
-43 Reduced 0.61%
7,029 $1.37 Million
Q3 2018

Oct 30, 2018

BUY
$185.29 - $208.89 $159,349 - $179,645
860 Added 13.84%
7,072 $1.47 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $4,151 - $4,662
-25 Reduced 0.4%
6,212 $1.15 Million
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $13,840 - $15,464
-82 Reduced 1.3%
6,237 $1.09 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $1.06 Million - $1.21 Million
6,319
6,319 $1.18 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.